HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1006302780216 -
GGREM
513423100034306 -
Barcode
7897406120745
What the source publishes
- Holder
- INSTITUTO BIOCHIMICO INDÚSTRIA FARMACÊUTICA LTDA
- Active ingredients
- HEMITARTARATO DE RIVASTIGMINA
- Package
- 1,5 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
- Supply regime
- Tarja Vermelha sob restrição
- Product type
- Genérico
- Therapeutic class
- N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
- Prescription
- Prescription or restricted
Names this record is found by
- HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30
- HEMITARTARATO DE RIVASTIGMINA
Complete source data
{
"name": "HEMITARTARATO DE RIVASTIGMINA 1,5 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30",
"holder": "INSTITUTO BIOCHIMICO INDÚSTRIA FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7897406120745"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "513423100034306",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.258.401/0001-03",
"priceRegime": "Regulado",
"productName": "HEMITARTARATO DE RIVASTIGMINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "1,5 MG CAP DURA OR CT BL AL PLAS PVDC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "135.73",
"icms-12": "154.24",
"icms-17": "163.53",
"icms-18": "165.52",
"icms-19": "167.57",
"icms-20": "169.66",
"icms-21": "171.81",
"icms-22": "174.01",
"icms-23": "176.27",
"icms-17.5": "164.52",
"icms-19.5": "168.61",
"icms-20.5": "170.73",
"icms-22.5": "175.14",
"icms-12-alc": "152.39",
"icms-17-alc": "161.57",
"icms-18-alc": "163.54",
"icms-19-alc": "165.56",
"icms-20-alc": "167.63",
"icms-21-alc": "169.75",
"icms-22-alc": "171.92",
"icms-23-alc": "174.16",
"withoutTaxes": "134.10",
"icms-17.5-alc": "162.55",
"icms-19.5-alc": "166.59",
"icms-20.5-alc": "168.68",
"icms-22.5-alc": "173.03"
},
"pisCofinsList": "Positiva",
"substanceText": "HEMITARTARATO DE RIVASTIGMINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "187.09",
"icms-12": "212.60",
"icms-17": "225.41",
"icms-18": "228.15",
"icms-19": "230.98",
"icms-20": "233.86",
"icms-21": "236.82",
"icms-22": "239.85",
"icms-23": "242.97",
"icms-17.5": "226.77",
"icms-19.5": "232.41",
"icms-20.5": "235.33",
"icms-22.5": "241.41",
"icms-12-alc": "210.67",
"icms-17-alc": "223.36",
"icms-18-alc": "226.08",
"icms-19-alc": "228.88",
"icms-20-alc": "231.74",
"icms-21-alc": "234.67",
"icms-22-alc": "237.67",
"icms-23-alc": "240.77",
"withoutTaxes": "185.39",
"icms-17.5-alc": "224.72",
"icms-19.5-alc": "230.30",
"icms-20.5-alc": "233.19",
"icms-22.5-alc": "239.20"
},
"invalidBarcodes": [],
"activeSubstances": [
"HEMITARTARATO DE RIVASTIGMINA"
],
"therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006302780216",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N7D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:513423100034306"